Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
| dc.contributor.author | Cardoso, F. | |
| dc.contributor.author | Lin, C. | |
| dc.contributor.author | Gradishar, W. | |
| dc.contributor.author | Azevedo, S. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Bachelot, T. | |
| dc.contributor.author | Royce, M. | |
| dc.contributor.author | Villanueva, C. | |
| dc.contributor.author | Melo Cruz, F. | |
| dc.contributor.author | Hegg, R. | |
| dc.contributor.author | Falkson, C. | |
| dc.contributor.author | Jeong, J. | |
| dc.contributor.author | Srimuninnimit, V. | |
| dc.contributor.author | Arce, C. H. | |
| dc.contributor.author | Ridolfi, A. | |
| dc.date.accessioned | 2021-03-03T19:08:09Z | |
| dc.date.available | 2021-03-03T19:08:09Z | |
| dc.identifier.citation | Bachelot T., Royce M., Villanueva C., Melo Cruz F., Hegg R., Falkson C., Jeong J., Srimuninnimit V., Arce C. H. , Ridolfi A., et al., "Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4", 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_52e581a7-2c23-44e6-9ca3-8f094a81f02d | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/58814 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.title | Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4 | |
| dc.type | Bildiri | |
| dc.contributor.department | UNICANCER , , | |
| dc.identifier.volume | 28 | |
| dc.contributor.firstauthorID | 152192 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]